Author Archives: Darren Marchal

Incyte Upgraded To Buy From Neutral At UBS

UBS analyst Carter Gould upgraded Incyte (INCY) to Buy while lowering his price target for the shares to $76 from $106. The stock offers an improved risk/reward profile after resetting lower on negative epacadostat Phase 3 data and removal of the drug from analyst models, Gould tells investors in a research note. The focus on…

Morning Call For Thursday, April 12

Overnight Markets And News Jun E-mini S&Ps (ESM18 +0.45%) this morning are up +0.57% and European stocks are up +0.41% as the markets await President Trump’s decision on military action against Syria. President Trump tweeted this morning that he “never said when an attack on Syria would take place. Could be very soon or not so…

Indian Indices End Marginally Higher; Infosys Surges 3.4%

After opening their day on a flat note, Indian share markets witnessed volatile trading activity throughout the day and ended their session marginally higher. Gains were largely seen in the IT sector and banking sector, while realty stocks and metal stocks ended the day lower. At the closing bell, the BSE Sensex stood higher by 161 points (up 0.5%) and the NSE Nifty closed higher by 42 points…

March 2018 FOMC Meeting Minutes: Uncertainty About The Effects Of

The 21 March 2018 meeting statement presented the actions taken. This post covers the economic discussion during this FOMC meeting between the members (minutes were released today). There continued to be considerable discussion on inflation and timing on the next federal funds rate increase, and an interesting quote: … PCE price inflation rate would likely shift upward when the…